These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35155257)

  • 1. Pevonedistat Suppresses Pancreatic Cancer Growth
    Xu J; Li Z; Zhuo Q; Ye Z; Fan G; Gao H; Ji S; Yu X; Xu X; Liu W; Xu W
    Front Oncol; 2022; 12():822039. PubMed ID: 35155257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
    Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
    EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
    Olaizola P; Lee-Law PY; Fernandez-Barrena MG; Alvarez L; Cadamuro M; Azkargorta M; O'Rourke CJ; Caballero-Camino FJ; Olaizola I; Macias RIR; Marin JJG; Serrano-Maciá M; Martinez-Chantar ML; Avila MA; Aspichueta P; Calvisi DF; Evert M; Fabris L; Castro RE; Elortza F; Andersen JB; Bujanda L; Rodrigues PM; Perugorria MJ; Banales JM
    J Hepatol; 2022 Jul; 77(1):177-190. PubMed ID: 35217064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma.
    Zhou S; Zhao X; Yang Z; Yang R; Chen C; Zhao K; Wang W; Ma Y; Zhang Q; Wang X
    Int J Cancer; 2019 Aug; 145(3):763-774. PubMed ID: 31044422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma.
    Tong S; Si Y; Yu H; Zhang L; Xie P; Jiang W
    Sci Rep; 2017 Jul; 7(1):5599. PubMed ID: 28717191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).
    Wong KM; Micel LN; Selby HM; Tan AC; Pitts TM; Bagby SM; Spreafico A; Klauck PJ; Blakemore SJ; Smith PF; McDonald A; Berger A; Tentler JJ; Eckhardt SG
    Invest New Drugs; 2017 Feb; 35(1):11-25. PubMed ID: 27783255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
    Zhang W; Liang Y; Li L; Wang X; Yan Z; Dong C; Zeng MS; Zhong Q; Liu XK; Yu J; Sun S; Liu X; Kang J; Zhao H; Jeong LS; Zhang Y; Jia L
    Cell Prolif; 2019 Mar; 52(2):e12536. PubMed ID: 30341788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells.
    Wang X; Zhang W; Yan Z; Liang Y; Li L; Yu X; Feng Y; Fu S; Zhang Y; Zhao H; Yu J; Jeong LS; Guo X; Jia L
    Oncotarget; 2016 Jun; 7(25):38380-38391. PubMed ID: 27224919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
    Shapiro DD; Zacharias NM; Tripathi DN; Karki M; Bertocchio JP; Soeung M; He R; Westerman ME; Gao J; Rao P; Lam TNA; Jonasch E; Perelli L; Cheng EH; Carugo A; Heffernan TP; Walker CL; Genovese G; Tannir NM; Karam JA; Msaouel P
    Clin Transl Med; 2023 May; 13(5):e1267. PubMed ID: 37226898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer.
    Zeng Y; Iv YS; Pan QH; Zhou YG; Li H
    Oncol Lett; 2019 Sep; 18(3):2724-2732. PubMed ID: 31404297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of Cullin4 Ubiquitin Ligase in Malignant Pleural Mesothelioma.
    Meerang M; Kreienbühl J; Orlowski V; Müller SLC; Kirschner MB; Opitz I
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia.
    Guo N; Azadniv M; Coppage M; Nemer M; Mendler J; Becker M; Liesveld J
    Transl Oncol; 2019 Apr; 12(4):602-613. PubMed ID: 30699367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Protein Neddylation for Cancer Therapy.
    Zhou L; Jia L
    Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer.
    Jones TM; Carew JS; Bauman JE; Nawrocki ST
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
    Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
    Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein neddylation and its alterations in human cancers for targeted therapy.
    Zhou L; Zhang W; Sun Y; Jia L
    Cell Signal; 2018 Apr; 44():92-102. PubMed ID: 29331584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma.
    Wang J; Wang S; Zhang W; Wang X; Liu X; Liu L; Li L; Liang Y; Yu J; Jeong LS; Jia L; Zhao H; Zhang Y
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1183-1188. PubMed ID: 28669728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
    Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4-CHOP-DR5 Axis in Human Esophageal Cancer Cells.
    Chen P; Hu T; Liang Y; Li P; Chen X; Zhang J; Ma Y; Hao Q; Wang J; Zhang P; Zhang Y; Zhao H; Yang S; Yu J; Jeong LS; Qi H; Yang M; Hoffman RM; Dong Z; Jia L
    Clin Cancer Res; 2016 Aug; 22(16):4145-57. PubMed ID: 26983464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Mcl-1 enhances Pevonedistat-triggered apoptosis in osteosarcoma cells.
    Zhang Y; Shi C; Yin L; Zhou W; Wang H; Seng J; Li W
    Exp Cell Res; 2017 Sep; 358(2):234-241. PubMed ID: 28663057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.